Form S-8 Krystal Biotech, Inc.

Go back to Form S-8 Krystal Biotech, Inc.

Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List

February 26, 2024 11:26 AM EST

Evercore ISI analyst Josh Schimmer reiterated an Outperform rating and $168.00 price target on Krystal Biotech (NASDAQ: KRYS)

Removes from Tactical Outperform List.

For an analyst ratings summary and ratings history on Krystal Biotech... More